国际口腔医学杂志

国际口腔医学杂志 ›› 2018, Vol. 45 ›› Issue (4): 425-432.doi: 10.7518/gjkq.2018.04.010

• 综述 • 上一篇    下一篇

长链非编码RNA的研究进展及其与口腔肿瘤的关系

宋洪宁1, 王旭霞2, 张君2   

  1. 1.泰山医学院附属医院口腔颌面外科 泰安 271000;
    2.山东大学口腔医学院口腔颌面外科学教研室 济南 250012
  • 收稿日期:2017-08-13 修回日期:2018-03-27 出版日期:2018-07-02 发布日期:2018-07-02
  • 通讯作者: 宋洪宁,主治医师,硕士,Email：13665387902@163.com
  • 作者简介:宋洪宁,主治医师,硕士,Email：13665387902@163.com
  • 基金资助:
    山东省科学技术发展项目（2010GSF10239）; 山东省科学技术专项计划项目（2012G0021852）

Long non-coding RNA and its relationship with oral cancer

Song Hongning1, Wang Xuxia2, Zhang Jun2   

  1. 1. Dept. of Oral and Maxillofacial Surgery, Affiliated Hospital of Taishan Medical University, Taian 271000, China;
    2. Dept. of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, Jinan 250012, China
  • Received:2017-08-13 Revised:2018-03-27 Online:2018-07-02 Published:2018-07-02
  • Supported by:
    This study was supported by Science and Technology Development Funds of Shandong Province (2010GSF10239) and Science and Technology Development Special Funds of Shandong Province (2012G0021852).

RichHTML

3

PDF (PC)

620

摘要： 长链非编码RNA（lncRNA）是一类长度大于200 nt的不具备编码蛋白质功能的RNA,近年来才获得较多的关注,发现其在生命过程中发挥关键作用。越来越多的研究表明,lncRNA在细胞生理过程中扮演了重要的角色,包括细胞增殖、分化、凋亡、迁移、入侵和染色质重塑。更重要的是,lncRNA在肿瘤生物学和预后方面的作用越来越被认可,多项研究表明,lncRNA对肿瘤的生长和转移起重要作用,与多种肿瘤的预后不良相关,lncRNA可能是潜在的肿瘤标志物和治疗靶标。lncRNA被发现存在于多个肿瘤表达缺失,然而其对肿瘤发生、发展和转移的分子机制仍不完全明确。本文强调了lncRNA在肿瘤发病机制中的最新发现,总结概述了lncRNA在不同肿瘤中的表达和作用,发现lncRNA已经成为一类新的有前途的肿瘤标记物,许多独立研究证实其作为恶性肿瘤诊断、预后、预测和监测治疗反应工具的可行性。对lncRNA在肿瘤发生、发展中的作用的研究虽然仍处于初级阶段,但毫无疑问,了解lncRNA的活动必将改善肿瘤患者的治疗。

关键词: 长链非编码RNA, 肿瘤, 肿瘤标志物

Abstract: Long non-coding RNA (lncRNA) is a family of non-protein-coding RNAs with length of more than 200 nucleotides. These lncRNAs have gained considerable attention and recently emerged as main participants in biological processes. An increasing number of studies showed that lncRNAs play important roles in diverse cellular processes, including proliferation, differentiation, apoptosis, migration, invasion and chromatin remodelling. Importantly, lncRNAs are increasingly recognised in cancer biology and prognosis. Multiple studies also indicated that lncRNAs play important roles in tumour growth and metastasis and poor prognosis in multiple tumour types. These RNAs may also act as a potential biomarker and therapeutic target for human cancers. Furthermore, lncRNA deregulation is observed in multiple tumours. However, the molecular mechanism of lncRNAs in cancer initiation, progression and metastasis remains poorly understood. In this review, we highlight the recent findings on lncRNAs in cancer pathogenesis and summarise an overview of current knowledge concerning the expression and role of lncRNA in various cancers. Additionally, lncRNAs emerged as a new class of promising cancer biomarkers. Independent studies demonstrated the feasibility of their use as tools in the diagnosis and prognosis of different types of malignancies and in the prediction and possible monitoring treatment response. The role of lncRNAs in cancers is an emerging field of study. Although our understanding about the role of lncRNAs in the onset and progression of cancers is still in its infancy, further understanding the activities of lncRNAs will secure improved treatment options for cancer patients.

Key words: long non-coding RNA, cancer, cancer biomarker

中图分类号: 

  • Q52
[1] Djebali S, Davis CA, Merkel A, et al.Landscape of transcription in human cells[J]. Nature, 2012, 489(7414): 101-108.
[2] Liu J, Cheng G, Yang H, et al.Reciprocal regulation of long noncoding RNAs THBS4-003 and THBS4 control migration and invasion in prostate cancer cell lines[J]. Mol Med Rep, 2016, 14(2): 1451-1458.
[3] Okazaki Y, Furuno M, Kasukawa T, et al.Analysis of the mouse transcriptome based on functional an-notation of 60,770 full-length cDNAs[J]. Nature, 2002, 420(6915): 563-573.
[4] Al-Tassan NA, Whiffin N, Hosking FJ, et al.A new GWAS and meta-analysis with 1 000 genomes im-putation identifies novel risk variants for colorectal cancer[J]. Sci Rep, 2015, 5: 10442.
[5] Maass PG, Luft FC, Bähring S.Long non-coding RNA in health and disease[J]. J Mol Med, 2014, 92(4): 337-346.
[6] St laurent G, Wahlestedt C, Kapranov P. The land-scape of long noncoding RNA classification[J]. Trends Genet, 2015, 31(5): 239-251.
[7] Kan JY, Wu DC, Yu FJ, et al.Chemokine (C-C motif) ligand 5 is involved in tumorassociated den-dritic cell-mediated colon cancer progression through non-coding RNA MALAT-1[J]. J Cell Physiol, 2015, 230(8): 1883-1894.
[8] Schaukowitch K, Kim TK.Emerging epigenetic mechanisms of long non-coding RNAs[J]. Neuro-science, 2014, 264: 25-38.
[9] Maass PG, Luft FC, Bähring S.Long non-coding RNA in health and disease[J]. J Mol Med, 2014, 92(4): 337-346.
[10] Zhao XY, Li S, Wang GX, et al.A long noncoding RNA transcriptional regulatory circuit drives thermo-genicadipocyte differentiation[J]. Mol Cell, 2014, 55(3): 372-382.
[11] Monnier P, Martinet C, Pontis J, et al.H19 lncRNA controls gene expression of the imprinted gene net-work by recruiting MBD1[J]. Proc Natl Acad Sci USA, 2013, 110(51): 20693-20698.
[12] Charlton J, Williams RD, Sebire NJ, et al.Compara-tive methylome analysis identifies new tumour sub-types and biomarkers for transformation of nephro-genic rests into Wilms tumour[J]. Genome Med, 2015, 7(1): 11.
[13] Lv J, Ma L, Chen XL, et al.Downregulation of lnc-RNA H19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway[J]. J Huazhong Univ Sci Technol (Med Sci), 2014, 34(3): 363-369.
[14] Li H, Yu B, Li J, et al.Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer[J]. Oncotarget, 2014, 5(8): 2318-2329.
[15] Zhou X, Ye F, Yin C, et al.The interaction between MiR-141 and lncRNA-H19 in regulating cell pro-liferation and migration in gastric cancer[J]. Cell Physiol Biochem, 2015, 36(4): 1440-1452.
[16] Zhang HM, Yang FQ, Chen SJ, et al.Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma[J]. Tumour Biol, 2015, 36(4): 2947-2955.
[17] Jadaliha M, Zong X, Malakar P, et al.Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative ly-mph node negative breast cancer[J]. Oncotarget, 2016, 7(26): 40418-40436.
[18] Wang W, Zhu Y, Li S, et al.Long noncoding RNA MALAT1 promotes malignant development of eso-phageal squamous cell carcinoma by targeting β- catenin via Ezh2[J]. Oncotarget, 2016, 7(18): 25668-25682.
[19] Dong Y, Liang G, Yuan B, et al.MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway[J]. Tumour Biol, 2015, 36(3): 1477-1486.
[20] Hauptman N, Glavač D.Long non-coding RNA in cancer[J]. Int J Mol Sci, 2013, 14(3): 4655-4669.
[21] Endo H, Shiroki T, Nakagawa T, et al.Enhanced ex- pression of long non-coding RNA HOTAIR is asso-ciated with the development of gastric cancer[J]. PLoS One, 2013, 8(10): e77070.
[22] Huang J, Ke P, Guo L, et al.Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of en-dometrial carcinoma cells in vitro and in vivo[J]. Int J Gynecol Cancer, 2014, 24(4): 635-642.
[23] Fang K, Liu P, Dong S, et al.Magnetofection based on superparamagnetic iron oxide nanoparticle-me-diated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells[J]. Int J Oncol, 2016, 49(2): 509-518.
[24] Gutschner T, Diederichs S.The hallmarks of cancer: a long non-coding RNA point of view[J]. RNA Biol, 2012, 9(6): 703-719.
[25] Peng W, Wu G, Fan H, et al.Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and pro-motes tumorigenesis in gastric cancer[J]. Tumour Biol, 2015, 36(9): 6751-6758.
[26] Jing W, Gao S, Zhu M, et al.Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular car-cinoma[J]. Oncol Rep, 2016, 36(2): 1085-1092.
[27] Smith CM, Steitz JA.Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5’-terminal oligopyrimidine gene family reveals common features of snoRNA host genes[J]. Mol Cell Biol, 1998, 18(12): 6897-6909.
[28] Pickard MR, Mourtada-Maarabouni M, Williams GT.Long non-coding RNA GAS5 regulates apop-tosis in prostate cancer cell lines[J]. Biochim Biophys Acta, 2013, 1832(10): 1613-1623.
[29] Liu Z, Wang W, Jiang J, et al.Downregulation of GAS5 promotes bladder cancer cell proliferation, partly byregulating CDK6[J]. PLoS One, 2013, 8(9): e73991.
[30] Chen L, Yang H, Xiao Y, et al.Lentiviral-mediated overexpression of long non-coding RNA GAS5 re-duces invasion by mediating MMP2 expression and activity in human melanoma cells[J]. Int J Oncol, 2016, 48(4): 1509-1518.
[31] Lu KH, Li W, Liu XH, et al.Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and in-duces apoptosis by affecting p53 expression[J]. BMC Cancer, 2013, 13: 461.
[32] Qin R, Chen Z, Ding Y, et al.Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis[J]. Neoplasma, 2013, 60(5): 486-492.
[33] Chang L, Wang G, Jia T, et al.Armored long non-coding RNA MEG3 targeting EGFR based on re-combinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma[J]. Oncotarget, 2016, 7(17): 23988-24004.
[34] Flockhart RJ, Webster DE, Qu K, et al.BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration[J]. Genome Res, 2012, 22(6): 1006-1014.
[35] Sun M, Liu XH, Wang KM, et al.Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesen-chymal transition[J]. Mol Cancer, 2014, 13(1): 68.
[36] Gibb EA, Enfield KS, Stewart GL, et al.Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions[J]. Oral Oncol, 2011, 47(11): 1055-1061.
[37] Wu Y, Zhang L, Zhang L, et al.Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E- cadherin in oral squamous cell carcinoma[J]. Int J Oncol, 2015, 46(6): 2586-2594.
[38] Jia LF, Wei SB, Gan YH, et al.Expression, regula-tion and roles of miR-26a and MEG3 in tongue squa-mous cell carcinoma[J]. Int J Cancer, 2014, 135(10): 2282-2293.
[39] Gao W, Chan JY, Wong TS.Long non-coding RNA deregulation in tongue squamous cell carcinoma[J].Biomed Res Int, 2014, 2014: 405860.
[1] 和子慕, 李风兰. 数字化口腔定位支架在头颈部肿瘤放射治疗中的应用现状[J]. 国际口腔医学杂志, 2024, 51(1): 28-35.
[2] 傅豫, 何薇, 黄兰. 铁死亡在口腔疾病中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 36-44.
[3] 周金阔,张晋弘,史晓晶,刘广顺,姜磊,刘倩峰. 长链非编码RNA小核仁RNA宿主基因22调控微小RNA-27b-3p对口腔鳞状细胞癌细胞增殖、侵袭和迁移的影响[J]. 国际口腔医学杂志, 2024, 51(1): 52-59.
[4] 吴佳敏,夏斌,杨禾丰,许彪. 癌相关成纤维细胞在口腔鳞状细胞癌微环境中作用的研究进展[J]. 国际口腔医学杂志, 2023, 50(6): 711-717.
[5] 赵玲帆, 周杨, 叶鑫鑫, 张强. 肾移植术后腮腺低分化黏液表皮样癌1例[J]. 国际口腔医学杂志, 2023, 50(4): 419-422.
[6] 张超颖,李怡宁,龚佳幸,王慧明. 2022年世界卫生组织指南头颈部肿瘤分类的解读：牙源性和颌面部骨肿瘤[J]. 国际口腔医学杂志, 2023, 50(3): 263-271.
[7] 盛南宁,王珏,南欣荣. 性别决定基因盒9在口腔鳞状细胞癌作用机制和治疗中的研究进展[J]. 国际口腔医学杂志, 2023, 50(3): 314-320.
[8] 李春洁, 毕小琴, 朱桂全. 口腔颌面部肿瘤患者游离皮瓣修复术的并发症预防及处理[J]. 国际口腔医学杂志, 2023, 50(2): 127-137.
[9] 李潭,梁新华. 盘状蛋白结构域受体1在调控恶性肿瘤进展和治疗中的作用[J]. 国际口腔医学杂志, 2023, 50(2): 230-236.
[10] 罗婉逸,韩居熺,周学东,彭显,郑欣. 具核梭杆菌促进结直肠癌发生发展机制的研究进展[J]. 国际口腔医学杂志, 2023, 50(1): 52-60.
[11] 洪娅娅,陈学鹏,姒蜜思. 非编码RNA调控牙囊干细胞成骨分化的研究进展[J]. 国际口腔医学杂志, 2022, 49(3): 263-271.
[12] 甘建国,高攀,王晓毅. 循环肿瘤细胞与口腔鳞状细胞癌相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 205-212.
[13] 沈洁,何地,刘雁鸣. 下颌下腺良性肿瘤功能性手术的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 230-237.
[14] 孔利心,任彪,程磊. 环氧合酶2/前列腺素E2通路调控口腔肿瘤机制的研究进展[J]. 国际口腔医学杂志, 2020, 47(4): 431-438.
[15] 崔钰嘉,孙建勋,周学东. 黄连素的生物学功能及治疗口腔疾病研究的进展[J]. 国际口腔医学杂志, 2020, 47(1): 115-120.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 张京剧. 青年期至中年期颅面复合体变化的头影测量研究[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 刘玲. 镍铬合金中铍对可铸造性和陶瓷金属结合力的影响[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 王昆润. 在种植体上制作固定义齿以后下颌骨密度的动态变化[J]. 国际口腔医学杂志, 1999, 26(06): .
[4] 王昆润. 重型颌面部炎症死亡和康复病例的实验室检查指标比较[J]. 国际口腔医学杂志, 1999, 26(06): .
[5] 逄键梁. 两例外胚层发育不良儿童骨内植入种植体后牙槽骨生长情况[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 温秀杰. 氟化物对牙本质脱矿抑制作用的体外实验研究[J]. 国际口腔医学杂志, 1999, 26(05): .
[7] 杨春惠. 耳颞神经在颞颌关节周围的分布[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 王昆润. 牙周炎加重期应选用何种抗生素[J]. 国际口腔医学杂志, 1999, 26(04): .
[9] 杨儒壮 孙宏晨 欧阳喈. 纳米级高分子支架材料在组织工程中的研究进展[J]. 国际口腔医学杂志, 2004, 31(02): 126 -128 .
[10] 严超然,李龙江. 肿瘤靶向药物载体系统的研究进展[J]. 国际口腔医学杂志, 2008, 35(S1): .